Drug Trial Radar · NCT03199911
Topical Antibiotic Prophylaxis for Eyelids
Last checked: Nov 19, 2026Latest source record: Jul 21, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
401
Actual
Start
Oct 2, 2017
Primary completion
Nov 14, 2019
Study completion Nov 14, 2019
Sponsor
- Lead sponsor
- University of California, San FranciscoAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jun 27, 2017
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The investigators propose a prospective randomized control trial testing the hypothesis that routine topical antibiotic prophylaxis does not significantly reduce the rate of infection after eyelid surgery.
Conditions
- Antibiotic Side Effect
- Eyelid; Wound
- Eyelid Diseases
- Surgical Wound Infection
- Surgical Wound, Recent
- Surgical Incision
- Skin Cancer Face
- Antibiotic Allergy
- Surgical Site Infection
Interventions
Topical Antibiotic ProductDrug
Topical antibiotic ointment will be erythromycin or bacitracin. If the patient cannot obtain either (e.g. lack of availability at the pharmacy), bacitracin polymyxin will be prescribed. Allergy to all 3 study drugs means that a patient will be excluded from the study.
Topical Non-Antibiotic OintmentDrug
Mineral oil/petrolatum-based artificial tear ointment.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Surgical Site InfectionsTime frame: First Post-Operative Visit (~7-14 days)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of California, San Francisco
San Francisco, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.